This article first appeared on GuruFocus. Colgate-Palmolive (NYSE:CL) delivered better-than-expected organic sales growth in the fourth quarter, supported by a recovery in Latin America following a ...
Colgate-Palmolive (NYSE:CL) delivered another quarter of organic sales and earnings per share growth in the face of what it described as very difficult market conditions worldwide. Organic sales rose ...
Colgate posts Q2 sales of $5.058 billion, beating the analyst consensus estimate of $5.010 billion. Colgate raises its organic sales growth outlook to 6% - 8% (prior view of 5% - 7%).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results